18F-Fluciclovine PET/CT A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma

被引：1
|
作者：
Marcus, Charles [1 ]
Schuster, David M. [1 ]
Tajmir, Shahein Holmes [1 ]
机构：
[1] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA USA
来源：
CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 09期
关键词：
F-18-fluciclovine; multiple myeloma; PET/CT; prostate cancer; POSITRON-EMISSION-TOMOGRAPHY;
D O I：
10.1097/RLU.0000000000004271
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Incidental concomitant second primary malignancy may be detected on PET/CT imaging. We present an F-18-fluciclovine PET/CT of a patient undergoing evaluation of biochemically recurrent prostate cancer with incidental radiotracer uptake within lytic osseous lesions confirmed to be multiple myeloma. We present the F-18-fluciclovine PET/CT images of an 83-year-old man with prostate cancer treated in 2005 who presented with back pain and a CT scan revealing multiple lytic osseous lesions concerning for metastases versus a plasma cell neoplasm. Prostate-specific antigen at the time of evaluation was 0.1 ng/mL.
引用
收藏
页码：E613 / E615
页数：3
相关论文
共 50 条
  • [21] Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Caroline Stokke
    Jakob Nordberg Nørgaard
    Hilde Feiring Phillips
    Alexander Sherwani
    Syed Nuruddin
    James Connelly
    Fredrik Schjesvold
    Mona-Elisabeth Revheim
    Molecular Imaging and Biology, 2022, 24 : 842 - 851
  • [22] Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer
    Tina M. Buehner
    Margaret Liotta
    Ronald K. Potkul
    Robert H. Wagner
    Bital Savir-Baruch
    Molecular Imaging and Biology, 2024, 26 : 45 - 52
  • [23] Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Stokke, Caroline
    Norgaard, Jakob Nordberg
    Phillips, Hilde Feiring
    Sherwani, Alexander
    Nuruddin, Syed
    Connelly, James
    Schjesvold, Fredrik
    Revheim, Mona-Elisabeth
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (05) : 842 - 851
  • [24] Incidental Serous Cystadenoma Presenting as a Photopenic Pancreatic Defect on 18F-Fluciclovine PET/CT
    Waltz, Jeffrey
    Mercer, Megan K.
    Dani, Genta
    Rieter, William J.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (12) : E600 - E602
  • [25] Incidentally Detected Oropharyngeal Squamous Cell Carcinoma on 18F-Fluciclovine PET/CT
    Raghavan, Kesav
    Wen, Kwun Wah
    Small, Eric J.
    Ha, Patrick
    Flavell, Robert R.
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) : E367 - E369
  • [26] 18F-Fluciclovine PET/MRI in a Patient With Squamous Cell Carcinoma of the Uterine Cervix Correlated With 18F-FDG PET/CT
    Nguyen, Nghi C.
    Moon, Chan Hong
    Beriwal, Sushil
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : 802 - 804
  • [27] Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning
    Wang, Tonghe
    Lei, Yang
    Schreibmann, Eduard
    Roper, Justin
    Liu, Tian
    Schuster, David M.
    Jani, Ashesh B.
    Yang, Xiaofeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] 18F-Fluciclovine (FACBC) and Its Potential Use for Breast Cancer Imaging
    McConathy, Jonathan
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (09) : 1329 - 1330
  • [29] Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
    Miller, Matthew P.
    Kostakoglu, Lale
    Pryma, Daniel
    Yu, Jian Qin
    Chau, Albert
    Perlman, Eric
    Clarke, Bonnie
    Rosen, Donald
    Ward, Penelope
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (10) : 1596 - 1602
  • [30] Negative 18F-Piflufolastat PET/CT, But Positive 18F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer
    Ulaner, Gary A.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 968 - 970
12345